Erythema nodosum leprosum
Information
- Disease name
- Erythema nodosum leprosum
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04822909 | Completed | Phase 4 | A Study to Evaluate the Efficacy and Safety of Apremilast in Patients of Chronic and Recurrent Erythema Nodosum Leprosum | September 15, 2019 | June 30, 2020 |
| NCT03775460 | Recruiting | N/A | Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum | January 15, 2023 | December 1, 2024 |
| NCT03807362 | Recruiting | Phase 2 | CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum | January 7, 2018 | December 31, 2024 |
| NCT00406861 | Unknown status | N/A | Montelukast in ENL Reaction | December 2006 | June 2009 |
- MedGen concept unique identifier (MedGen Concept name)
- C0343467
- MedGen unique identifier (MedGen Concept name)
- 575612